MethylGene Announces Second Quarter 2006 Results

August 9, 2006 |

1 min read

MethylGene Inc. (TSX: MYG) a biopharmaceutical company focused on epigenetic regulation, today announced operational and financial results for the second quarter ended June 30, 2006.

Earnings

MORE ON THIS TOPIC

Lost at sea strategic crisis and strategy trouble concept as a target floating aimlessly in an ocean of confused blue darts as a business metaphor for economic or corporate plan despair as a 3D illustration.

Cell therapy

Agenus cancer cocktail records 0% response rate, missing midstage goal

April 20, 2026

·

2 min read

·

Gabrielle Masson

IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch

IPO tracker

Odyssey tests IPO waters anew after quitting quest last year

April 20, 2026

·

10 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

BMS layoffs hits Lawrenceville hard, adding 200+ to cut count

April 20, 2026

·

49 min read

·

BioSpace Editorial Staff

Online Medicine or internet pharmacy services as a pharmacist or web doctor and medical health service or digital healthcare for purchase and delivery of medications as Telemedicine and Teleconsultations.

GLP-1

Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch

April 17, 2026

·

1 min read

·

Tristan Manalac